Literature DB >> 9480395

[Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus].

R H Straub1, T Andus, G Lock, M Zeuner, K D Palitzsch, V Gross, B Lang, J Schölmerich.   

Abstract

BACKGROUND: During the last years, examination of autonomic nervous function and of autonomic neuropathy has attracted attention not only in diabetes mellitus research but also in other areas of internal medicine. However, patients with various chronic diseases with autoimmune phenomenons have never been investigated in a comparative study with standardized examination techniques. Hence, the aim of the study was to examine the prevalence and the severity of autonomic neuropathy in patients with the following chronic diseases. PATIENTS AND METHODS: We investigated 28 patients with Crohn's disease (CD: age: 32.4 +/- 2.0 y), 17 patients with ulcerative colitis (UC: 39.7 +/- 3.6 y), 39 patients with systemic lupus erythematosus (SLE: 34.9 +/- 2.0 y), 38 patients with progressive systemic sclerosis (pSS; 51.5 +/- 2.4 y) and 65 patients with insulin-dependent diabetes mellitus (IDDM: 35.5 +/- 1.6 y). Cardiovascular autonomic (cANP), pupillary autonomic (pANP), and sensorimotor (ssNP) neuropathy were assessed by standardized techniques.
RESULTS: Prevalence rates for cANP, pANP and ssNP were found to be 0%, 19%, and 7% in CD, 6%, 25%, and 18% in UC, 5%, 29%, and 10% in SLE, 11%, 16%, and 32% in pSS, and 26%, 66%, and 29% in IDDM, respectively.
CONCLUSION: The study demonstrated patients with IDDM to have the highest prevalence rates of cANP and pANP. Patients with other chronic diseases, particularly SLE, pSS and UC, had high prevalence rates of pANP. This may be due to alterations of structures of the central nervous system in these patients. cANP was rare in patients with inflammatory bowel disease and ssNP was found very often in patients with pSS, probably due to local fibrotic lesions. The various disease groups differ in the pattern and severity of autonomic and sensorimotor neuropathy, which indicates that different structures and neuropathogenic mechanisms may be involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9480395     DOI: 10.1007/bf03044820

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  45 in total

1.  The pathogenesis of central nervous system manifestations of systemic lupus erythematosus.

Authors:  N J Zvaifler; H G Bluestein
Journal:  Arthritis Rheum       Date:  1982-07

2.  Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Autonomic brake index and heart-rate variation.

Authors:  S L Rabinowe; F M Brown; M Watts; A M Smith
Journal:  Diabetes Care       Date:  1990-10       Impact factor: 19.112

3.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

4.  Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation.

Authors:  A Hietaharju; S Jääskeläinen; M Hietarinta; H Frey
Journal:  Acta Neurol Scand       Date:  1993-05       Impact factor: 3.209

5.  Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.

Authors:  O Schnell; C M Kirsch; J Stemplinger; M Haslbeck; E Standl
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

Review 6.  Pathogenesis and prevention of diabetic neuropathy.

Authors:  D A Greene; S A Lattimer; A A Sima
Journal:  Diabetes Metab Rev       Date:  1988-05

7.  Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population.

Authors:  H A Neil; A V Thompson; S John; S T McCarthy; J I Mann
Journal:  Diabet Med       Date:  1989 Jan-Feb       Impact factor: 4.359

8.  Evidence of vagal neuropathy in chronic alcoholics.

Authors:  G Duncan; R H Johnson; D G Lambie; E A Whiteside
Journal:  Lancet       Date:  1980-11-15       Impact factor: 79.321

9.  Autonomic neural dysfunction in recently diagnosed diabetic subjects.

Authors:  M A Pfeifer; C R Weinberg; D L Cook; A Reenan; J B Halter; J W Ensinck; D Porte
Journal:  Diabetes Care       Date:  1984 Sep-Oct       Impact factor: 19.112

10.  Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes.

Authors:  K P Ratzmann; M Raschke; I Gander; E Schimke
Journal:  J Diabet Complications       Date:  1991 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.